Caliway Biopharmaceuticals C stock sits at TWD 76.50, 1.86 percent above its low
Published on 10/13/2026 at 14:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Caliway Biopharmaceuticals C stock sat at TWD 76.50 on the Taiwan Stock Exchange on October 13, 2026, 1.86 percent above its 52-week low of TWD 75.10. The current quote was TWD 76.50 at 1:30 p.m. CST, minus 0.91 percent versus the prior close of TWD 77.20.
Results date is November 11
Investing.com lists November 11, 2026 as Caliway Biopharmaceuticals' next earnings date. The calendar entry covers the period ending September 2026, giving the market a defined date for the next reported operating update.
Price position near yearly low
The stock's 52-week range was TWD 75.10 to TWD 188.00 on October 13, 2026. Its latest quote therefore stood 59.31 percent below the 52-week high, while the session volume reached 4,384,371 shares against an average volume of 7,003,197.
The quote also places the stock close to the bottom of its annual range: the TWD 76.50 price was TWD 1.40 above the low. That placement matters because the current level is 59.31 percent below the high, despite the company remaining an actively traded Taiwan biotechnology name.
Valuation and Taiwan peers
Market capitalization was TWD 119.1 billion on October 13, 2026, while the trailing P/E ratio was minus 474.27 and the dividend yield was 0.00 percent. TradingView identifies ticker 6919 as listed on the Taiwan Stock Exchange.
Comparison with peers
Caliway Biopharmaceuticals C (Taiwan Stock Exchange, TWD): minus 0.91 percent, P/E minus 474.27, market capitalization TWD 119.1 billion.
PharmaEssentia (Taiwan Stock Exchange, TWD): minus 1.69 percent, P/E 58.63, market capitalization TWD 480.6 billion.
Medigen Vaccine Biologics (Taipei Exchange, TWD): minus 4.98 percent, P/E minus 107.63, market capitalization TWD 18.2 billion.
Taiwan quote sets the final marker
The Taiwan-listed stock was last quoted at TWD 76.50 on October 13, 2026 at 1:30 p.m. CST, minus 0.91 percent versus the prior close of TWD 77.20. The price frame combines a TWD 119.1 billion market capitalization with a 52-week range of TWD 75.10 to TWD 188.00.
Caliway Biopharmaceuticals C market data
- Company: Caliway Biopharmaceuticals Co., Ltd.
- ISIN: TW0006919004
- Ticker: 6919
- Primary exchange: Taiwan Stock Exchange
- Price on Taiwan Stock Exchange (as of October 13, 2026, 1:30 p.m. CST): TWD 76.50
- Change versus prior close: minus 0.91 percent
- Prior close (October 12, 2026): TWD 77.20
- Market capitalization: TWD 119.1 billion (as of October 13, 2026)
- 52-week range: TWD 75.10-188.00 (as of October 13, 2026)
- Sector / Industry: Healthcare / Biotechnology
- Next earnings date: November 11, 2026
Market context: Market report TAIEX.
More news and analyses on Caliway Biopharmaceuticals C stock
